9000M
2021-07-01

$Abcam plc(ABCM)$ Unfortunately seems like a less known biotech company.  As someone using their products on a regular basis, the company is known in the research community for their quality products. It is a well-established company and although quite limited in their product portfolio, they do have uniqueness. I am just surprised that so many of the biotech companies that are literary just “selling” an idea (= candidate drug in clinical trials and many many years away from a potential product) or relatively new companies like Twist bioscience (which is as limited as Abcam in their product profile) have such high trading volumes. Just wondering why, the trading volume of Abcam is low.

SGX Stocks Opportunities
Share SGX companies' analysis and opportunities with Tigers!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment